Lack of Transparency Tarnishes Sarepta's Sheen as Patient Deaths Trigger FDA Battle on July 23, 2025 Elevidys gene therapy lack of transparency Market Muscular Dystrophies, Limb-Girdle Muscular Dystrophy, Duchenne patient deaths Regulatory Action United States Food and Drug Administration Withdraw (activity) +